Characteristic | |
---|---|
Male | 50 (52%) |
Age, median (years) | 56 (range 20–78) |
CDS-VRE score, median† | 1.88 (range 0–4.97) |
Hematological malignancy | 83 (86%) |
AML | 40 (42%) |
Allogeneic stem cell transplant | 26 (27%) |
On antibiotics prior to BSI‡ | 91/93 (98%) |
Total antibiotic days prior to BSI, median‡ | 17 (range 0–65) |
Hospital admissions prior to BSI, median§ | 1 (range 0–10) |
Transfer from another hospital | 20 (21%) |
Days in hospital prior to BSI, median | 16 (range 0–129) |
ICU admission in 30 days prior to BSI | 31 (32%) |
In ICU at onset of BSI | 19 (20%) |
Neutropenic days prior to BSI, median | 11 (range 0–30) |
Neutropenic at time of BSI | 76 (79%) |
SIRS at time of BSI† | 86/94 (91%) |
Hypoalbuminemia days prior to BSI, median | 17.5 (range 0–30) |
Central venous access device¶ | 77/95 (81%) |
Tunnelled | 35/95 (37%) |
Indwelling urinary catheter† | 33/94 (35%) |
Mucositis grade, median‡ | 0 (range 0–4) |